Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 14, 2005; 11(18): 2822-2826
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2822
Table 5 The density comparison of proliferation and apoptosis with moderate dysplasia in model-agent group, sulindac-preventative group and sulindac-curative group (number/mm2).
GroupnProliferative cell density (mean±SD)Apoptotic cell density (mean±SD)Ratio (apoptosis/roliferation)
Model-agent9114.7±31.757.1±17.3a0.50
Preventive7118.9±21.4107.8±35.00.91
Curative3133.0±27.562.7±20.3a0.47